BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Genetown

  Glympse Reports Near-Perfect Accuracy with Liquid Biopsy to Predict NASH

  This liquid biopsy uses a panel of peptide biosensors to analyze protein activity from a blood sample and provide actionable readouts of the disease state.

  November 22, 2021

   · 

  4 min read

   · 

  Gail Dutton
• 

  FDA

  Bluebird Spreads Wings After Company Split; REGENXBIO Gets Orphan Nod

  The FDA has granted Cambridge-based bluebird Bio a Priority Review of its Biologics License Application for betibeglogene autotemcel (beti-cel).

  November 22, 2021

   · 

  2 min read

   · 

  Kate Goodwin
• 

  Drug Development

  Despite Positive Phase II Data, Connect Derm Drug Faces Tough Market

  Connect Biopharma shares plummeted 55% despite reported positive topline data from its Phase II trial of CBP-201 for adults with moderate-to-severe atopic dermatitis.

  November 22, 2021

   · 

  2 min read

   · 

  Mark Terry
• 

  Business

  Twist Bioscience Acquires Abveris to Complement Antibody Capabilities

  Twist Bioscience snapped up in vivo antibody discovery company Abveris Inc. in a deal valued at up to $190 million. The acquisition is expected to bolster Twist’s biopharma antibody capabilities.

  November 22, 2021

   · 

  2 min read

   · 

  Alex Keown
• 

  Career Advice

  Prepare to Answer These Six Questions for Pharmaceutical Job Interviews

  Before going for pharmaceutical jobs interviews, you should be prepared to give the best answers possible. Here are six questions you should be ready for.

  November 22, 2021

   · 

  5 min read

   · 

  Alina Zahid
• 

  Drug Development

  Reading the Pattern: The Butterfly Effect and COVID-19 Patients

  If you are wondering what the butterfly effect is and how it affects COVID-19 patients, you have come to the right place. Here is everything you need to know.

  November 22, 2021

   · 

  5 min read

   · 

  Mishayl Hanan
• 

  Business

  Two Chinese Biopharmas Align in $200 Million IO Deal

  CStone forged a licensing agreement with Jiangsu Hengrui Pharmaceuticals that grants the company access to a monoclonal antibody aimed at multiple forms of cancer.

  November 22, 2021

   · 

  3 min read

   · 

  Alex Keown
• 

  Deals

  Novartis May Have a Suitor for Sandoz; Merck Closes Acceleron Deal

  After indicating it might entertain a sale, Novartis may receive an offer from investment group EQT and the Struengmann family for its generic unit Sandoz.

  November 22, 2021

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  Pfizer-BioNTech Vaccine Effective Long-Term in Teens; US Vaccine Data in 2076?

  News on COVID-19 vaccine developments and disease studies continue to deliver highs and lows. Here are some of the more recent happenings.

  November 22, 2021

   · 

  6 min read

   · 

  Vanessa Doctor, RN
• 

  Business

  Neurocrine Commits Potential $2.6 Billion to Sosei Heptares, Neuropsychiatric Disorders

  Under the strategic collaboration, Neurocrine Biosciences and Sosei Group Corporation will develop and commercialize novel muscarinic receptor agonists to treat the said illnesses.

  November 22, 2021

   · 

  2 min read

   · 

  Vanessa Doctor, RN